GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ThermoGenesis Holdings Inc (STU:THR) » Definitions » Cyclically Adjusted Price-to-FCF

ThermoGenesis Holdings (STU:THR) Cyclically Adjusted Price-to-FCF : (As of May. 25, 2024)


View and export this data going back to . Start your Free Trial

What is ThermoGenesis Holdings Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


ThermoGenesis Holdings Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for ThermoGenesis Holdings's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ThermoGenesis Holdings Cyclically Adjusted Price-to-FCF Chart

ThermoGenesis Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ThermoGenesis Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ThermoGenesis Holdings's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, ThermoGenesis Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ThermoGenesis Holdings's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ThermoGenesis Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where ThermoGenesis Holdings's Cyclically Adjusted Price-to-FCF falls into.



ThermoGenesis Holdings Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

ThermoGenesis Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, ThermoGenesis Holdings's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.12/131.7762*131.7762
=-0.120

Current CPI (Mar. 2024) = 131.7762.

ThermoGenesis Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -334.250 100.560 -438.011
201409 -780.750 100.428 -1,024.460
201412 -466.250 99.070 -620.176
201503 -816.500 99.621 -1,080.045
201506 -306.750 100.684 -401.478
201509 -266.000 100.392 -349.158
201512 -661.800 99.792 -873.909
201603 -577.000 100.470 -756.789
201606 -176.000 101.688 -228.076
201609 -148.231 101.861 -191.764
201612 -29.455 101.863 -38.105
201703 -109.545 102.862 -140.337
201706 -87.682 103.349 -111.800
201709 -60.636 104.136 -76.731
201712 -77.727 104.011 -98.476
201803 -79.500 105.290 -99.499
201806 -115.765 106.317 -143.487
201809 -25.612 106.507 -31.689
201812 3.127 105.998 3.887
201903 -39.818 107.251 -48.923
201906 -8.258 108.070 -10.070
201909 -8.985 108.329 -10.930
201912 3.257 108.420 3.959
202003 -25.228 108.902 -30.527
202006 -40.671 108.767 -49.275
202009 -16.557 109.815 -19.868
202012 -11.835 109.897 -14.191
202103 -13.161 111.754 -15.519
202106 -4.211 114.631 -4.841
202109 -3.317 115.734 -3.777
202112 -1.189 117.630 -1.332
202203 -13.316 121.301 -14.466
202206 -3.468 125.017 -3.656
202209 -1.583 125.227 -1.666
202212 -1.160 125.222 -1.221
202303 -1.035 127.348 -1.071
202306 -0.521 128.729 -0.533
202309 -0.161 129.860 -0.163
202312 -0.566 129.419 -0.576
202403 -0.120 131.776 -0.120

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


ThermoGenesis Holdings  (STU:THR) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


ThermoGenesis Holdings Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of ThermoGenesis Holdings's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


ThermoGenesis Holdings (STU:THR) Business Description

Traded in Other Exchanges
Address
2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.